Pregnancy Decisions Among Women with HIV
- 406 Downloads
Nearly 80% of women currently infected with HIV are of childbearing age. As women of childbearing age continue to be at risk of contracting HIV, there will be an increased need for choices about whether or not to have biological children. The purpose of this exploratory study was to investigate the influence of partners, physicians, and family members on pregnancy decisions, as well as the impact of HIV stigma on these decisions. Results indicated that most women chose not to become pregnant since learning their HIV diagnosis and the woman’s age at the time of diagnosis is significantly associated with this decision. Additional factors included fear of transmitting HIV to their child, personal health-related concerns, and desire to have children. Women with a procreative inclination were more likely to choose to become pregnant which outweighed social support and personal health concerns. Implications and suggestions for future research are noted.
KeywordsHIV positive Pregnancy decisions Stigma Women
This work was funded by a grant from the National Institutes of Mental Health (R01MH62293). We thank the women who participated in this study.
- Anonymous (1999). Elective caesarian-section versus vaginal delivery in prevention of vertical HIV-1 transmission: A randomized clinical trial. The European Mode of Delivery Collaboration. Lancet, 353, 1035–1039.Google Scholar
- Centers for Disease Control and Prevention (1986). HIV/AIDS Surveillance Report: Year-end edition, 1985. Atlanta, GA.Google Scholar
- Centers for Disease Control and Prevention (2005). HIV/AIDS Surveillance Report. Atlanta, GA.Google Scholar
- Guay, L. A., Musoke, P., Fleming, T., Bagenda, D., Allen, M., Nakabiito, C., Herman, J. S., Bakaki, P., Ducar, C., Deseyve, M., Emel, L., Mirochnick, M., Fowler, M. G., Mofenson, L., Miotti, P., Dransfield, K., Bray, D., Mmiro, F., & Jackson, J.B (1999). Intrapartum and neonatal single-dose Nevirapine compared with Zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala Uganda. Lancet, 354, 795.PubMedGoogle Scholar
- Musoke, P., Guay, L. A., Bagenda, D., Mirochnick, M., Nakabiito, C., Fleming, T., Elliott, T., Horton, S., Dransfield, K., Pav, J. W., Murarka, A., Allen, M., Fowler, M. G., Mofenson, L., Hom, D., Mmiro, F., & Jackson, J. B. (1999) A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1 infected pregnant Ugandan women and their neonates. AIDS, 13, 479–486.Google Scholar
- Shaffer, N., Chuachoowong, R., Mock, P. A., Bhadrakom, C., Siriwasin, W., Young, N. L., Chotpitayasunondh, T., Chearskul, S., Roongpisuthipong, A., Chinayon, P., Karon, J., Mastro, T. D., Simonds, R. J., on behalf of the Bangkok Collaborative Perinatal HIV Transmission Study Group (1999). Short-course Zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: A randomized controlled trial. Lancet, 353, 773–780.Google Scholar
- Shapiro, M. F., Morton, S. C., McCaffrey, D. F., Senterfitt, J. W., Fleishman, J. A., Perlman, J. F., Athey, L. A., Keesey, J. W., Goldman, D. P., Berry, S. H., & Bozzette, S. A. (1999). Variations in the care of HIV-infected adults in the United States: Results from the HIV Cost and Services Utilization Study. Journal of the American Medical Association, 281, 2305–2315.PubMedCrossRefGoogle Scholar